Skip to content

Very Long Term VHI Voice Outcome After MTIS

Very Long Term VHI Voice Outcome After MTIS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02969993
Enrollment
53
Registered
2016-11-21
Start date
2016-12-31
Completion date
2017-10-19
Last updated
2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal Paralysis

Brief summary

Long term assesment of voice outcome after Montgomery Thyroplastie by performing a Survey of operated patients using the voice handicap index scale

Interventions

OTHERQuestionnaires

evaluating the voice outcome by the fullfilment of the voice handicap index

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients presenting UVFP of neurogenic origin treated by MTIS \> 2 years before inclusion. * No superior limit in terms of years. * Age 18-80 years at the time of MTIS * No other treatment before MTIS other than resorbing material injection laryngoplasty (maximum twice) * No further voice treatment after MTIS except speech therapy. * VHI or VHI-10 performed before MTIS and within the 6 months after MTIS. In case of multiple post-op VHI tests, only the earliest post-op. VHI test will be taken into account * VHI tests validated for the utilized language

Exclusion criteria

* patient not able to answer VHI questionnaire personally * Post MTIS new health condition affecting the voice tract and/ or the respiratory function. * Post MTIS appearance of other voice/ vocal cord pathology

Design outcomes

Primary

MeasureTime frameDescription
Voice handicap index2 yearsQuestionnaire

Countries

Belgium, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026